EA202191193A1 - CHIMERIC ANTIGENIC RECEPTORS SPECIFIC FOR G-PROTEIN-CONNECTED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D) - Google Patents
CHIMERIC ANTIGENIC RECEPTORS SPECIFIC FOR G-PROTEIN-CONNECTED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D)Info
- Publication number
- EA202191193A1 EA202191193A1 EA202191193A EA202191193A EA202191193A1 EA 202191193 A1 EA202191193 A1 EA 202191193A1 EA 202191193 A EA202191193 A EA 202191193A EA 202191193 A EA202191193 A EA 202191193A EA 202191193 A1 EA202191193 A1 EA 202191193A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- gprc5d
- protein
- group
- receptor class
- receptors specific
- Prior art date
Links
- 230000000890 antigenic effect Effects 0.000 title 1
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 abstract 3
- 102100021197 G-protein coupled receptor family C group 5 member D Human genes 0.000 abstract 3
- 101001040713 Homo sapiens G-protein coupled receptor family C group 5 member D Proteins 0.000 abstract 3
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 abstract 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 abstract 1
- 238000011467 adoptive cell therapy Methods 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Изобретение относится к химерным антигенным рецепторам (CAR), которые содержат части антител, специфичных к сопряженному с G белком рецептору класса С группы 5 члена D (GPRC5D), и полинуклеотидам, которые кодируют CAR, специфичные к GPRC5D. Описание также относится к генетически сконструированным клеткам, содержащим такие GPRC5D-связывающие рецепторы, и из применению в адоптивной клеточной терапии.The invention relates to chimeric antigen receptors (CAR), which contain portions of antibodies specific to the G protein-coupled receptor of class C group 5 of member D (GPRC5D), and polynucleotides that encode CARs specific for GPRC5D. The disclosure also relates to genetically engineered cells containing such GPRC5D binding receptors and of use in adoptive cell therapy.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962904197P | 2019-09-23 | 2019-09-23 | |
| PCT/US2019/059285 WO2020092854A2 (en) | 2018-11-01 | 2019-10-31 | Chimeric antigen receptors specific for g protein-coupled receptor class c group 5 member d (gprc5d) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202191193A1 true EA202191193A1 (en) | 2021-09-29 |
Family
ID=77912697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202191193A EA202191193A1 (en) | 2019-09-23 | 2019-10-31 | CHIMERIC ANTIGENIC RECEPTORS SPECIFIC FOR G-PROTEIN-CONNECTED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D) |
Country Status (1)
| Country | Link |
|---|---|
| EA (1) | EA202191193A1 (en) |
-
2019
- 2019-10-31 EA EA202191193A patent/EA202191193A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2025010458A (en) | Chimeric antigen receptors specific for g protein-coupled receptor class c group 5 member d (gprc5d) | |
| PH12020552138A1 (en) | Bcma chimeric antigen receptors and uses thereof | |
| EA202192103A1 (en) | ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC TO ORPHAN RECEPTOR TYPE OF RECEPTOR TYROSINE KINASE 1 (ROR1) | |
| EA202091982A1 (en) | Chimeric antigenic receptor to the receptor of IL-13 ALPHA 2 (IL13R2) for tumor-specific T-cell immunotherapy | |
| EA202191939A1 (en) | CHIMERIC ANTIGENIC GPRC5D RECEPTORS AND EXPRESSING THEIR CELLS | |
| PE20212305A1 (en) | ANTIBODIES AGAINST IL-7R ALPHA SUBUNIT AND USES OF THESE | |
| AR110676A1 (en) | TREATMENT OF CANCER USING CHEMERIC ANTIGENS RECEPTORS | |
| MY209480A (en) | Ilt-binding agents and methods of use thereof | |
| PE20220495A1 (en) | CHIMERIC ANTIGENIC RECEPTORS AND BINDING AGENTS TARGETING DLL3 | |
| MX2020010235A (en) | EXPRESSION VECTORS FOR CHIMERIC ENGINEERING RECEPTORS, GENETICALLY MODIFIED HOST CELLS AND USES THEREOF. | |
| EA201992469A1 (en) | ANTIGEN SPECIFIC IMMUNE EFFECTIVE CELLS | |
| MX2022006709A (en) | Anti-idiotypic antibodies to bcma-targeted binding domains and related compositions and methods. | |
| MX2019001184A (en) | Anti-idiotypic antibodies against anti-cd19 antibodies. | |
| JOP20190248A1 (en) | Trem2 antigen binding proteins and uses thereof | |
| EP4424376A3 (en) | Chimeric antigen receptors based on single-domain antibodies and methods of use thereof | |
| PH12022551462A1 (en) | Ilt3-binding agents and methods of use thereof | |
| WO2015142675A8 (en) | Treatment of cancer using chimeric antigen receptor | |
| MX2020008803A (en) | Cd83-binding chimeric antigen receptors. | |
| MX2025000925A (en) | Chimeric antigen receptors specific for gprc5d and bcma | |
| EA202190915A1 (en) | COMPOSITIONS AND METHODS FOR CONSTRUCTED AND UNCONSTRUCTED T-CELLS FOR THE TREATMENT OF SOLID TUMORS | |
| EA202191193A1 (en) | CHIMERIC ANTIGENIC RECEPTORS SPECIFIC FOR G-PROTEIN-CONNECTED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D) | |
| EA202190424A1 (en) | METHOD FOR ASSESSING FUNCTIONAL STATE OF CHIMERIC ANTIGENIC RECEPTOR (CAR) | |
| AR116943A1 (en) | RECEPTORS FOR CHEMERIC ANTIGENS SPECIFIC TO THE RECEPTOR COUPLED TO PROTEIN G CLASS C, GROUP 5, MEMBER D (GPRC5D) | |
| EA202092006A1 (en) | CD83-BINDING CHIMERIC ANTIGENIC RECEPTORS | |
| MX2025006813A (en) | Anti-idiotype CD70 antibodies |